US Patent

US8741959 — Paracetamol for parenteral administration

Formulation · Assigned to Fresenius Kabi Deutschland GmbH · Expires 2030-04-19 · 4y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration containing paracetamol.

USPTO Abstract

The invention relates to an aqueous pharmaceutical composition, preferably an infusion solution, for parenteral administration which contains paracetamol and has an electrical conductivity of not more than 200 Î¼S cm â1 .

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

Patent Metadata

Patent number: US8741959
Jurisdiction: US
Classification: Formulation
Expires: 2030-04-19
Drug substance claim: No
Drug product claim: Yes
Assignee: Fresenius Kabi Deutschland GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.